Drawing for AMIDI

USPTO serial 79232007

AMIDI

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
BURDECKI, ANNA C
Law office
TTAB

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 604: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with AMIDI?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Martin W. Schiffmiller

MARTIN W SCHIFFMILLER KIRSCHSTEIN ISRAEL SCHIFFMILLER & PIERON425 FIFTH AVENUE 5TH FLOORSUITE 501NEW YORK, NY 10016-2223

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations, namely, diagnostic reagents for medical and veterinary use, for medical in-vitro analysis and diagnosis in humans and animals, integrated in an electronic device, consisting of one or more chipsABANDONED—
009Software, including mobile applications, for performing an in-vitro analysis and medical diagnosis in humans and animals, the storing and recording of this data and for transmitting the information recorded; computer software platforms for enabling users to operate, cluster, view, track and to research data related to health; electronic chips, namely, semiconductor chipsABANDONED—
010Analysis and diagnostic devices for medical use, integrated in an electronic device, consisting of one or more chips, namely, apparatus for performing a medical in-vitro analysis and medical diagnosis in humans and animalsABANDONED—
042Providing scientific and technological services and research and design relating thereto, namely, research and design in the field of in-vitro diagnostics, medical research and scientific research information in the field of pharmaceuticals and clinical trials; medical research and scientific study and research in scientific and biotechnological facilities, namely, research in health care with regard to the production, validation, development, storage, transport, and use of an electronic device consisting of one or more chips, integrated pharmaceutical compositions and in-vitro analysis, and diagnostic tools; designing, installing, maintaining, developing and updating software, mobile software applications and computer software platforms; consultancy and providing information regarding the aforesaid services, including provided via electronic networks such as the internetABANDONED—
044Medical services and services in the field of healthcare, namely, healthcare and providing healthcare informationABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 26, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jan 8, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jul 23, 2023ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Sep 18, 2021ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Sep 26, 2020FINTFINAL DECISION TRANSACTION PROCESSED BY IB—
Sep 5, 2020FICSFINAL DISPOSITION NOTICE SENT TO IB—
Aug 23, 2020FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Aug 26, 2019MAB4ABANDONMENT NOTICE E-MAILED - INTER PARTES DECISION—
Aug 23, 2019ABN4ABANDONMENT - AFTER INTER PARTES DECISION—
Aug 23, 2019OP.TOPPOSITION TERMINATED NO. 999999—
Aug 23, 2019OP.SOPPOSITION SUSTAINED NO. 999999—
Jun 1, 2019RFNTREFUSAL PROCESSED BY IB—
May 13, 2019OP.IOPPOSITION INSTITUTED NO. 999999—
May 6, 2019OPNSOPPOSITION NOTICE (IB REFUSAL) SENT TO IB—
May 4, 2019OPNCOPPOSITION NOTICE (IB REFUSAL) CREATED—
Feb 13, 2019ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Jan 25, 2019GPNXNOTIFICATION PROCESSED BY IB—
Jan 15, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 15, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 9, 2019OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jan 9, 2019OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Dec 26, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 6, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 6, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 6, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 4, 2018ALIEASSIGNED TO LIE—
Nov 29, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 29, 2018ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 29, 2018REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 23, 2018RFNTREFUSAL PROCESSED BY IB—
Jun 1, 2018RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jun 1, 2018RFRRREFUSAL PROCESSED BY MPU—
May 29, 2018MAFRAPPLICATION FILING RECEIPT MAILED—
May 26, 2018RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
May 25, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 23, 2018DOCKASSIGNED TO EXAMINER—
May 23, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 18, 2018LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
May 17, 2018REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance